Literature DB >> 7042541

Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy.

D M Neville, R J Youle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042541     DOI: 10.1111/j.1600-065x.1982.tb00390.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  18 in total

1.  Reduction of graft-versus-host reactivity after small bowel transplantation: ex vivo treatment of intestinal allografts with an anti-T cell immunotoxin.

Authors:  C L Clark; G J Smith; P W Crane; B A Price; P A Lear; J W Fabre; R F Wood
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Cloning and expression of recombinant, functional ricin B chain.

Authors:  M S Chang; D W Russell; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

Review 3.  Treatment of lymphoid tumors with anti-idiotype antibodies.

Authors:  G T Stevenson; F K Stevenson
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Osmotically induced microinjection of ricin bypasses a ricin internalization defect in a Chinese hamster ovary mutant cell line.

Authors:  P C Ghosh; R B Wellner; H C Wu
Journal:  Mol Cell Biol       Date:  1984-07       Impact factor: 4.272

5.  Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.

Authors:  E S Vitetta; W Cushley; J W Uhr
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

Review 6.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

7.  A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity.

Authors:  W Z Wei; R J Massey; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

8.  In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.

Authors:  K S Webb; S N Liberman; J L Ware; P J Walther
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Penetration of anti-melanoma immunotoxin into multicellular tumor spheroids and cell kill effects.

Authors:  T Kikuchi; T Ohnuma; J F Holland; L E Spitler
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Effect of specific anti-human leukaemia immunotoxins on the colony formation by human haematopoietic progenitors and by human leukaemia cells.

Authors:  C K Tebbi; D Chervinsky; B K Seon
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.